TimesSquare Capital Management’s Core Laboratories CLB Stock Holding History

TimesSquare Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-190,100	Closed	-$11.3M	–	222
2018 Q4	$11.3M	Sell	190,100 -36,600	-16%	-$3.16M	0.1%	199
2018 Q3	$26.3M	Sell	226,700 -27,300	-11%	-$3.08M	0.17%	181
2018 Q2	$32.1M	Sell	254,000 -26,082	-9%	-$3.17M	0.21%	168
2018 Q1	$30.3M	Sell	280,082 -12,068	-4%	-$1.34M	0.21%	166
2017 Q4	$32M	Buy	+292,150	New	+$29.2M	0.21%	158
2015 Q2	–	Sell	-165,900	Closed	-$17.3M	–	252
2015 Q1	$17.3M	Buy	+165,900	New	+$17.7M	0.09%	218

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TimesSquare Capital Management's CLB Position: Q1 2019 in Review

TimesSquare Capital Management sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 190,100 shares — an estimated $11.3M sold.

TimesSquare Capital Management first reported a position in CLB in Q1 2015 and held it in 6 quarters. The position peaked at $32.1M in Q2 2018. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

TimesSquare Capital Management reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
TimesSquare Capital Management sold 190,100 Core Laboratories shares in Q1 2019, an estimated $11.3M.
TimesSquare Capital Management first reported a position in Core Laboratories in Q1 2015 and held it in 6 quarters.
TimesSquare Capital Management's Core Laboratories position peaked at $32.1M in Q2 2018.
313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on TimesSquare Capital Management's 13F filing for Q1 2019, filed 10 May 2019.